Up next

Autoplay

Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic myeloma

0 Views • 08/18/25
Share
Side Effects
Side Effects
Subscribers
0

Dr Raje speaks with ecancer at the 16th International Myeloma Workshop about an international, randomised, double blind trial comparing denosumab with zoledronic acid for the treatment of bone disease in patients with newly diagnosed multiple myeloma.

Show more
0 Comments sort Sort By

Up next

Autoplay